Immune Regulation in Hematopoietic Cell Transplantation (Q58415034)

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

In vivo imaging of graft-versus-host-disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Plasticity of CD4+ T cell lineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Control of regulatory T cell lineage commitment and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

The PDL1-PD1 axis converts human TH1 cells into regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Foxp3+ Regulatory T-cells and IL-2: The Moirai of T-cell Fates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Multiple treg suppressive modules and their adaptability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Negative feedback regulation of T cells via interleukin-2 and FOXP3 reciprocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

High TCR diversity ensures optimal function andhomeostasis of Foxp3+regulatory Tcells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Stability of the regulatory T cell lineage in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Human T regulatory cell therapy: take a billion or so and call me in the morning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Association of Foxp3 regulatory gene expression with graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Presumed guilty: natural killer T cell defects and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

NKT cells, Treg, and their interactions in bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Tolerance and chimerism after renal and hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Host-residual invariant NK T cells attenuate graft-versus-host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Mesenchymal stromal cells: a new tool against graft-versus-host disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Generation and regulation of CD8(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14

Reduced Frequency of Regulatory T Cells in Peripheral Blood Stem Cell Compared to Bone Marrow Transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9781118416426.CH14